Lesley E. Smythies
Research Subjects
Research Interests
Lesley E. Smythies has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Phillip D. Smith
Department of Medicine (Gastroenterology) University of Alabama at Birmingham Birmingham AL USA
6 shared publications Diane Bimczok
Division of Gastroenterology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
3 shared publicationsD Bimczok
Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
2 shared publicationsLea Novak
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294; and
2 shared publicationsSatya Dandekar
Department of Medical Microbiology and Immunology, University of California, Davis, Davis, CA 95616
2 shared publicationsA L Fox
Department of Medicine (Gastroenterology), University of Alabama at Birmingham, Birmingham, USA
1 shared publication
Latest Publications
- Open Access
- 9 October 2023
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (19)
ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression
The role of aberrant glycosylation in pancreatic ductal adenocarcinoma (PDAC) remains an under-investigated area of research. In this study, we determined that ST6 β-galactoside α2,6 sialyltransferase 1 (ST6GAL1), which adds α2,6-linked sialic acids to N-glycosylated proteins, was upregulated in patients with early-stage PDAC and was further increased in advanced disease. A tumor-promoting function for ST6GAL1 was elucidated using tumor xenograft experiments with human PDAC cells. Additionally, we developed a genetically engineered mouse (GEM) model with transgenic expression of ST6GAL1 in the pancreas and found that mice with dual expression of ST6GAL1 and oncogenic KRAS G12D had greatly accelerated PDAC progression compared with mice expressing KRAS G12D alone. As ST6GAL1 imparts progenitor-like characteristics, we interrogated ST6GAL1’s role in acinar to ductal metaplasia (ADM), a process that fosters neoplasia by reprogramming acinar cells into ductal, progenitor-like cells. We verified ST6GAL1 promotes ADM using multiple models including the 266-6 cell line, GEM-derived organoids and tissues, and an in vivo model of inflammation-induced ADM. EGFR is a key driver of ADM and is known to be activated by ST6GAL1-mediated sialylation. Importantly, EGFR activation was dramatically increased in acinar cells and organoids from mice with transgenic ST6GAL1 expression. These collective results highlight a glycosylation-dependent mechanism involved in early stages of pancreatic neoplasia.
- 9 October 2023
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (19)
Open AccessST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression
The role of aberrant glycosylation in pancreatic ductal adenocarcinoma (PDAC) remains an under-investigated area of research. In this study, we determined that ST6 β-galactoside α2,6 sialyltransferase 1 (ST6GAL1), which adds α2,6-linked sialic acids to N-glycosylated proteins, was upregulated in patients with early-stage PDAC and was further increased in advanced disease. A tumor-promoting function for ST6GAL1 was elucidated using tumor xenograft experiments with human PDAC cells. Additionally, we developed a genetically engineered mouse (GEM) model with transgenic expression of ST6GAL1 in the pancreas and found that mice with dual expression of ST6GAL1 and oncogenic KRAS G12D had greatly accelerated PDAC progression compared with mice expressing KRAS G12D alone. As ST6GAL1 imparts progenitor-like characteristics, we interrogated ST6GAL1’s role in acinar to ductal metaplasia (ADM), a process that fosters neoplasia by reprogramming acinar cells into ductal, progenitor-like cells. We verified ST6GAL1 promotes ADM using multiple models including the 266-6 cell line, GEM-derived organoids and tissues, and an in vivo model of inflammation-induced ADM. EGFR is a key driver of ADM and is known to be activated by ST6GAL1-mediated sialylation. Importantly, EGFR activation was dramatically increased in acinar cells and organoids from mice with transgenic ST6GAL1 expression. These collective results highlight a glycosylation-dependent mechanism involved in early stages of pancreatic neoplasia.
- 1 December 2014
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 193 (11) , 5604-5612
Cytomegalovirus Enhances Macrophage TLR Expression and MyD88-Mediated Signal Transduction To Potentiate Inducible Inflammatory Responses
Circulating monocytes carrying human CMV (HCMV) migrate into tissues, where they differentiate into HCMV-infected resident macrophages that upon interaction with bacterial products may potentiate tissue inflammation. In this study, we investigated the mechanism by which HCMV promotes macrophage-orchestrated inflammation using a clinical isolate of HCMV (TR) and macrophages derived from primary human monocytes. HCMV infection of the macrophages, which was associated with viral DNA replication, significantly enhanced TNF-α, IL-6, and IL-8 gene expression and protein production in response to TLR4 ligand (LPS) stimulation compared with mock-infected LPS-stimulated macrophages during a 6-d in vitro infection. HCMV infection also potentiated TLR5 ligand–stimulated cytokine production. To elucidate the mechanism by which HCMV infection potentiated inducible macrophage responses, we show that infection by HCMV promoted the maintenance of surface CD14 and TLR4 and TLR5, which declined over time in mock-infected macrophages, and enhanced both the intracellular expression of adaptor protein MyD88 and the inducible phosphorylation of IκBα and NF-κB. These findings provide additional information toward elucidating the mechanism by which HCMV potentiates bacteria-induced NF-κB–mediated macrophage inflammatory responses, thereby enhancing organ inflammation in HCMV-infected tissues.
- 1 December 2014
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 193 (11) , 5604-5612
Cytomegalovirus Enhances Macrophage TLR Expression and MyD88-Mediated Signal Transduction To Potentiate Inducible Inflammatory Responses
Circulating monocytes carrying human CMV (HCMV) migrate into tissues, where they differentiate into HCMV-infected resident macrophages that upon interaction with bacterial products may potentiate tissue inflammation. In this study, we investigated the mechanism by which HCMV promotes macrophage-orchestrated inflammation using a clinical isolate of HCMV (TR) and macrophages derived from primary human monocytes. HCMV infection of the macrophages, which was associated with viral DNA replication, significantly enhanced TNF-α, IL-6, and IL-8 gene expression and protein production in response to TLR4 ligand (LPS) stimulation compared with mock-infected LPS-stimulated macrophages during a 6-d in vitro infection. HCMV infection also potentiated TLR5 ligand–stimulated cytokine production. To elucidate the mechanism by which HCMV infection potentiated inducible macrophage responses, we show that infection by HCMV promoted the maintenance of surface CD14 and TLR4 and TLR5, which declined over time in mock-infected macrophages, and enhanced both the intracellular expression of adaptor protein MyD88 and the inducible phosphorylation of IκBα and NF-κB. These findings provide additional information toward elucidating the mechanism by which HCMV potentiates bacteria-induced NF-κB–mediated macrophage inflammatory responses, thereby enhancing organ inflammation in HCMV-infected tissues.
- Open Access
- 24 September 2014
- Published by Elsevier in Mucosal Immunology
- Vol. 8 (3) , 533-544
Human gastric epithelial cells contribute to gastric immune regulation by providing retinoic acid to dendritic cells
- 24 September 2014
- Published by Elsevier in Mucosal Immunology
- Vol. 8 (3) , 533-544
Open AccessHuman gastric epithelial cells contribute to gastric immune regulation by providing retinoic acid to dendritic cells
- Open Access
- 17 March 2014
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 5, 104
Exosomes in the gut
Recent studies have highlighted the importance of cross-talk between our immune systems and our gut microbiota, the complex community of over 100 trillion commensal microorganisms (bacteria, archaea, fungi, and protozoans) that resides in the human gastrointestinal tract and which numbers about 10 times the total cells in the human body (1). The gut microbiota contribute profoundly to the function and structure of the gastrointestinal mucosa, establishing a robust network that provides us with increased digestive capacity for essential nutrients and non-nutrient factors, such as vitamins. It also protects us from infection by pathogenic microbes (2). Dysbiosis, or unbalanced shifts in the composition of the microbiota, may contribute to inflammatory bowel disease and necrotizing enterocolitis in premature infants, and are also increasingly linked to rheumatoid arthritis, multiple sclerosis, diabetes, and asthma, as well as obesity (2). The gastrointestinal tract, which is the largest mucosal surface in the body (with a surface area of about 300 m3 in adults), is lined by a single layer of polarized columnar epithelial cells firmly bound to one another by tight junctions and covered by a stratified mucus layer, that together provide a barrier containing the microbiota within the lumen. Cross-talk between the microbiota and immune cells of the mucosa [dendritic cells (DCs) and macrophages], communicated through this barrier, has regulated the evolution and development of our immune systems (3–6) and differentiated our ability to recognize and distinguish between beneficial and pathogenic microbes. Microbe recognition is achieved through epithelial cell and immune cell expression of germline-encoded pattern recognition receptors (PRRs) that bind discrete microbe-associated molecular patterns (MAMPS) expressed by both commensal and pathogenic microbes (7–9). PRR expression is tightly regulated on the apical and basolateral surfaces of the epithelial cells, such that binding of PRRs can activate a series of host defense reactions, including the directed release of soluble mediators, depending upon the nature of the antigen and the polarized epithelial surface communicating with the bacteria. Intestinal DCs orchestrate and direct mucosal adaptive immune responses, balancing immune tolerance to harmless antigens and effector responses against enteric pathogens (10). To facilitate these functions, populations of intestinal macrophages, and DCs, strategically located in the sub-epithelial lamina propria (11), sample luminal antigens provided by specialized epithelial cells (goblet cells) (12) or by inserting dendrites between epithelial cells into the lumen (13–15), and phagocytose pathogenic microbes that encroach into the mucosa (11). DCs expressing the mucosal marker CD103, migrate to the MLNs, where they present acquired mucosal antigenic molecules to responsive naïve T cells (16, 17), inducing the expansion of tolerogenic or effector memory T cell populations expressing the gut homing markers α4β7 and CCR9 (18, 19), that support the T cell recruitment to the lamina propria. In addition to the release of soluble mediators, epithelial cells also release a wide variety of proteins, lipids, mRNAs, and microRNAs contained within secreted nanovesicles, or exosomes, that are formed inside the secreting cells in endosomal compartments called multi-vesicular bodies (MVBs) (20, 21). Apical secretion of exosomes into the lumen may modulate the function of distant cells along the gastrointestinal tract, or regulate the homeostasis of gut microbiota, through delivery of antimicrobial products (22). Exosomes released basolaterally into the mucosa may also regulate local innate responses to invading bacteria through microbicidal activity (22). Moreover, epithelial cell-derived exosomes released into the mucosa may be taken up by mucosal DCs and transported to the MLNs, where their contents can effect the direction of mucosal adaptive immune responses, thereby directing the education of tolerogenic CD4+ T cell populations in conditions of homeostasis, as well as effector CD4+ T cells required to combat pathogenic microorganisms during microbial invasion or infection of the intestinal mucosa. Thus, intestinal epithelial cell-derived exosomes containing αvβ6 integrin and food antigen are reported to induce TGF-β+ tolerogenic DCs and antigen-specific TGF-β+ T regulatory cells, whereas food antigens in the absence of exosomes, induce a Th2-skewed response (23). Conversely, exosomes contribute to protection against luminal infection with the protozoan parasite Cryptosporidium parvum, where activation of TLR4/IKK2 signaling and the promotion of the SNAP23-associated vesicular exocytotic process (22) induces the formation and release of exosomes into the lumen that contain epithelial cell-derived antimicrobial peptides, including cathelicidin-37 and beta-defensin 2. Inhibition of this TLR4 signaling decreases exosomal content, reducing the ability of the cell to target antimicrobial peptides against the infectious agent locally, and perhaps influencing host antigen presentation against the bacterium systemically (22) – important evidence that exosome contents are regulated by events occurring locally in the cells from which the exosomes derive. Taken together these data suggest that epithelial cell-derived exosomes play an important role, informing not only local innate immune responses, but also DC induction of adaptive immune responses, to luminal microbiota. Exosomes were first isolated from cultured cells, but are now known to be released from many cells including red blood cells, platelets, epithelial cells, lymphocytes, DCs, tumor cells (24–27). Exosome cargo is stringently regulated by the immune condition of the cells forming the vesicles, and their transfer, by direct cell–cell contact or across gap junctions or synapses, facilitates the exchange of molecular messages, even over considerable distances. In the formation of exosomes, all types of cell so far examined bud off from their plasma membranes small lipoprotein vesicles (around 80 mm) that contain a wide variety of molecules including proteins, various types of RNA including mRNAs and microRNAs, DNA, lipid, and saccharides (28). Exosomes are constructed inside MVBs within the donor cell by invagination of its membrane. A complex mechanism then uploads a number of specific molecules into the exosome as its cargo. The MVB is then trafficked to the plasma membrane with which it fuses to release the contained exosomes into “extracellular space.” Importantly, the exosomal lipoprotein vesicular coats protect the exosome cargo from degradation (29), even from highly destructive elements such as catabolic enzymes found within phagolysosomes, thus it is likely that exosomes remain undamaged when taken up by DCs in the mucosa. Within the lymph node, transfer of cargo from the DC to the T cell is thought to involve the immune synapse (IS), which is intimately involved in antigen presentation between DCs and T cells. Exosomes are taken up within the IS by calveoli- or clathrin-dependent mechanisms (30, 31), and transported to specific loci in the receiving cell, including the perinuclear zone, where the vesicle opens and the cargo is released. A model for the transfer of exosomes across the IS may be provided by the manner by which an exosome probably crosses the synapse between neurons. The traditional picture of a synapse was that the axon terminal and the postsynaptic spine are separated by “extracellular space” filed with cytoplasm. The exosome was pictured as crossing this fluid cytoplasm. However, electron microscopy shows that such “space” is vanishingly thin. Instead, the “space” is mainly filled with astrocyte cuffs tightly packed around the central part of the synapse plus a network of nanotubes and fibers crossing the central part (32–35). This central part is specialized for the transmission of neurotransmitter molecules, and the outer ring for the transmission of exosomes (36). Astrocytes both receive (37) and bud off (38, 39) exosomes, so it is likely that exosomes cross the synapse via the astrocyte cuff and nanotubules. Much of the load carried by exosomes consists of epigenetic material (protein transcription factors, a wide variety of RNAs, and lengths of DNA). Epigenetic material consists of four main categories: (a) molecules that act directly on DNA by promoting co-valent binding (e.g., DNA methylases and demethylases) or non-co-valent binding (e.g., protein transcription factors); (b) agents that module the accessibility of DNA by promoting co-valent binding to histones (e.g., histone methylases and acetylases); (c) mRNAs that induce de novo protein synthesis in the target cell; and (d) micro RNAs that bind to mRNAs and modulate their activity (28). Exosomes from different types of cell carry different patterns of these transcription factors in their loads. In many cells, such as neurons, exosome formation is closely modulated by the degree of activity of that cell. For example, activation of glutamate receptors leads to a marked increase in exosome production mediated by calcium inflow. The exact composition of exosome loads is also exquisitely sensitive to the functional condition of the donor cell. For example, when a normal cell becomes cancerous, the ingredients of the load that its exosomes carry changes dramatically (28). Furthermore, the surfaces of different types of exosomes carry different patterns of glycosylation that can act as identifying signals, so that the exosome will bind to complementary patterns of glycosylation on the correct target cell (40). Other possible identification molecules that would allow an exosome to bind to its proper target are the heparin sulfate proteoglycans (HSPGs). Exosomes have been shown to enter cells via HSPG-mediated endocytosis. Heparanse enzyme activity is required for robust enhancement of exosome secretion (41–44). Exosomes from cancer cells depend on cell-surface HSPGs for their internalization and functional activity (30). This scenario offers an exciting new paradigm. Firstly, exosomes released from the apical or basolateral surface of gastrointestinal epithelium may contribute to antimicrobial defenses in the gut lumen. Secondly, and more interestingly, exosomes may be transported to the MLN where they modulate, by the epigenetic mechanisms listed above, host adaptive responses to luminal antigens. We are thus suggesting that there are two channels of communication between intestinal epithelial cells and target T cells in lymph nodes. The first transmits information (“software”) reflecting the contents of the gut, obtained and transmitted by DCs in the manner described earlier. The second channel transmits epigenetic instructions, in particular specific miRNAs, via exosomes to the T cell, so that it can develop the optimum molecular mechanisms or reactions (“hardware”) to process the incoming “software.” A similar system is found in the nervous system (28): information about the environment is transmitted by spike codes in axons (“software”) and instructions on how to best process this software is transmitted by epigenetic molecules via contained within exosomes. Together this results in changes in the basic functions of the receiving neurons by altering the synthesis of key proteins that play an essential role in these processes. Funding support is provided by National Institutes of Health grant AI-83539, The Broad Medical Research Program of The Broad Foundation, and The Crohn’s and Colitis Foundation of America. We are grateful to Sasha Vlassov for the benefit of helpful information. 1. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 124:837–48. doi: 10.1016/j.cell.2006.02.017 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 2. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature (2012) 489:231. doi:10.1038/nature11551 CrossRef Full Text 3. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev (1998) 62:1157. Pubmed Abstract | Pubmed Full Text 4. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol (2004) 4:478. doi:10.1038/nri1373 CrossRef Full Text 5. Duan J, Chung H, Troy E, Kasper DL. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe (2010) 7:140. doi:10.1016/j.chom.2010.01.005 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 6. Niess JH, Leithäuser F, Adler G, Reimann J. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol (2008) 180:559. Pubmed Abstract | Pubmed Full Text 7. Lundin A, Bok CM, Aronsson L, Björkholm B, Gustafsson JA, Pott S, et al. Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication that tunes innate immunity in large intestine. Cell Microbiol (2008) 10:1093. doi:10.1111/j.1462-5822.2007.01108.x Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 8. Smythies LE, Shen R, Bimczok D, Novak L, Clements RH, Eckhoff DE, et al. Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation. J Biol Chem (2010) 285:19593–604. doi:10.1074/jbc.M109.069955 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 9. Smith PD, Smythies LE, Shen R, Greenwell-Wild T, Gliozzi M, Wahl SM. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2011) 1:31–42. doi:10.1038/mi.2010.66 CrossRef Full Text 10. Farache J, Koren I, Milo I, Gurevich I, Kim K-W, Zigmond E, et al. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity (2013) 38:581–95. doi:10.1016/j.immuni.2013.01.009 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 11. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest (2005) 115:66–75. doi:10.1172/JCI200519229 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 12. McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, Knoop KA, et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature (2012) 483:345–9. doi:10.1038/nature10863 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 13. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (2005) 307:254–8. Pubmed Abstract | Pubmed Full Text 14. Chieppa M, Rescigno M, Huang AY, Germain RN. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp Med (2006) 203:2841–52. doi:10.1084/jem.20061884 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 15. Farache J, Zigmond E, Shakhar G, Jung S. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense. Immunol Cell Biol (2013) 91:232–9. doi:10.1038/icb.2012.79 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 16. Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, et al. Origin of the lamina propria dendritic cell network. Immunity (2009) 31:513–25. doi:10.1016/j.immuni.2009.08.010 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 17. Schulz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW, et al. Intestinal CD103þ, but not CX3CR1þ, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med (2009) 206:3101–14. doi:10.1084/jem.20091925 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 18. Johansson-Lindbom B, Svensson M, Pabst O, Palmqvist C, Marquez G, Förster R, et al. Functional specialization of gut CD103 dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med (2005) 202:1063–73. doi:10.1084/jem.20051100 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 19. Jaensson E, Uronen-Hansson H, Pabst O, Eksteen B, Tian J, Coombes JL, et al. Small intestinal CD103þ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med (2008) 205:2139–49. doi:10.1084/jem.20080414 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 20. Mallegol J, Van Niel G, Lebreton C, Lepelletier Y, Candalh C, Dugave C, et al. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells. J Gastro. (2007) 132:1866. doi:10.1053/j.gastro.2007.02.043 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 21. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology (2001) 121:337–49. 22. Hu G, Gong AY, Roth AL, Huang BQ, Ward HD, Zhu G, et al. Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. Plos Pathog (2013) 9. doi:10.1371/journal.ppat.1003261 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 23. Chen X, Song CH, Feng BS, Li TL, Li P, Zheng PY, et al. Intestinal epithelial cell-derived integrin αβ6 plays an important role in the induction of regulatory T cells and inhibits an antigen-specific Th2 response. J Leuko Biol (2006) 90:751–9. doi:10.1189/jlb.1210696 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 24. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol (2002) 2:569–79. 25. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet (2002) 360:295–305. doi:10.1016/S0140-6736(02)09552-1 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 26. Smalheiser NR. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct (2007) 2:35. doi:10.1186/1745-6150-2-35 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 27. Hendrix A, Westbroek W, Bracke M, Wever OD. An ex(o)citing machinery for invasive tumor growth. Cancer Res (2010) 70:9533–7. doi:10.1158/0008-5472.CAN-10-3248 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 28. Smythies J, Edelstein L. Transsynaptic modality codes in the brain: possible involvement of synchronized spike timing, microRNAs, exosomes and epigenetic processes. Front Intregr Neurosci (2013) 2012(6):126. doi:10.3389/fnint.2012.00126 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 29. Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med (2011) 9:86. doi:10.1186/1479-5876-9-86 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 30. Nanbo A, Kawanishi E, Yoshida R, Yoshiyama H. Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote...
- 17 March 2014
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 5, 104
Open AccessExosomes in the gut
Recent studies have highlighted the importance of cross-talk between our immune systems and our gut microbiota, the complex community of over 100 trillion commensal microorganisms (bacteria, archaea, fungi, and protozoans) that resides in the human gastrointestinal tract and which numbers about 10 times the total cells in the human body (1). The gut microbiota contribute profoundly to the function and structure of the gastrointestinal mucosa, establishing a robust network that provides us with increased digestive capacity for essential nutrients and non-nutrient factors, such as vitamins. It also protects us from infection by pathogenic microbes (2). Dysbiosis, or unbalanced shifts in the composition of the microbiota, may contribute to inflammatory bowel disease and necrotizing enterocolitis in premature infants, and are also increasingly linked to rheumatoid arthritis, multiple sclerosis, diabetes, and asthma, as well as obesity (2). The gastrointestinal tract, which is the largest mucosal surface in the body (with a surface area of about 300 m3 in adults), is lined by a single layer of polarized columnar epithelial cells firmly bound to one another by tight junctions and covered by a stratified mucus layer, that together provide a barrier containing the microbiota within the lumen. Cross-talk between the microbiota and immune cells of the mucosa [dendritic cells (DCs) and macrophages], communicated through this barrier, has regulated the evolution and development of our immune systems (3–6) and differentiated our ability to recognize and distinguish between beneficial and pathogenic microbes. Microbe recognition is achieved through epithelial cell and immune cell expression of germline-encoded pattern recognition receptors (PRRs) that bind discrete microbe-associated molecular patterns (MAMPS) expressed by both commensal and pathogenic microbes (7–9). PRR expression is tightly regulated on the apical and basolateral surfaces of the epithelial cells, such that binding of PRRs can activate a series of host defense reactions, including the directed release of soluble mediators, depending upon the nature of the antigen and the polarized epithelial surface communicating with the bacteria. Intestinal DCs orchestrate and direct mucosal adaptive immune responses, balancing immune tolerance to harmless antigens and effector responses against enteric pathogens (10). To facilitate these functions, populations of intestinal macrophages, and DCs, strategically located in the sub-epithelial lamina propria (11), sample luminal antigens provided by specialized epithelial cells (goblet cells) (12) or by inserting dendrites between epithelial cells into the lumen (13–15), and phagocytose pathogenic microbes that encroach into the mucosa (11). DCs expressing the mucosal marker CD103, migrate to the MLNs, where they present acquired mucosal antigenic molecules to responsive naïve T cells (16, 17), inducing the expansion of tolerogenic or effector memory T cell populations expressing the gut homing markers α4β7 and CCR9 (18, 19), that support the T cell recruitment to the lamina propria. In addition to the release of soluble mediators, epithelial cells also release a wide variety of proteins, lipids, mRNAs, and microRNAs contained within secreted nanovesicles, or exosomes, that are formed inside the secreting cells in endosomal compartments called multi-vesicular bodies (MVBs) (20, 21). Apical secretion of exosomes into the lumen may modulate the function of distant cells along the gastrointestinal tract, or regulate the homeostasis of gut microbiota, through delivery of antimicrobial products (22). Exosomes released basolaterally into the mucosa may also regulate local innate responses to invading bacteria through microbicidal activity (22). Moreover, epithelial cell-derived exosomes released into the mucosa may be taken up by mucosal DCs and transported to the MLNs, where their contents can effect the direction of mucosal adaptive immune responses, thereby directing the education of tolerogenic CD4+ T cell populations in conditions of homeostasis, as well as effector CD4+ T cells required to combat pathogenic microorganisms during microbial invasion or infection of the intestinal mucosa. Thus, intestinal epithelial cell-derived exosomes containing αvβ6 integrin and food antigen are reported to induce TGF-β+ tolerogenic DCs and antigen-specific TGF-β+ T regulatory cells, whereas food antigens in the absence of exosomes, induce a Th2-skewed response (23). Conversely, exosomes contribute to protection against luminal infection with the protozoan parasite Cryptosporidium parvum, where activation of TLR4/IKK2 signaling and the promotion of the SNAP23-associated vesicular exocytotic process (22) induces the formation and release of exosomes into the lumen that contain epithelial cell-derived antimicrobial peptides, including cathelicidin-37 and beta-defensin 2. Inhibition of this TLR4 signaling decreases exosomal content, reducing the ability of the cell to target antimicrobial peptides against the infectious agent locally, and perhaps influencing host antigen presentation against the bacterium systemically (22) – important evidence that exosome contents are regulated by events occurring locally in the cells from which the exosomes derive. Taken together these data suggest that epithelial cell-derived exosomes play an important role, informing not only local innate immune responses, but also DC induction of adaptive immune responses, to luminal microbiota. Exosomes were first isolated from cultured cells, but are now known to be released from many cells including red blood cells, platelets, epithelial cells, lymphocytes, DCs, tumor cells (24–27). Exosome cargo is stringently regulated by the immune condition of the cells forming the vesicles, and their transfer, by direct cell–cell contact or across gap junctions or synapses, facilitates the exchange of molecular messages, even over considerable distances. In the formation of exosomes, all types of cell so far examined bud off from their plasma membranes small lipoprotein vesicles (around 80 mm) that contain a wide variety of molecules including proteins, various types of RNA including mRNAs and microRNAs, DNA, lipid, and saccharides (28). Exosomes are constructed inside MVBs within the donor cell by invagination of its membrane. A complex mechanism then uploads a number of specific molecules into the exosome as its cargo. The MVB is then trafficked to the plasma membrane with which it fuses to release the contained exosomes into “extracellular space.” Importantly, the exosomal lipoprotein vesicular coats protect the exosome cargo from degradation (29), even from highly destructive elements such as catabolic enzymes found within phagolysosomes, thus it is likely that exosomes remain undamaged when taken up by DCs in the mucosa. Within the lymph node, transfer of cargo from the DC to the T cell is thought to involve the immune synapse (IS), which is intimately involved in antigen presentation between DCs and T cells. Exosomes are taken up within the IS by calveoli- or clathrin-dependent mechanisms (30, 31), and transported to specific loci in the receiving cell, including the perinuclear zone, where the vesicle opens and the cargo is released. A model for the transfer of exosomes across the IS may be provided by the manner by which an exosome probably crosses the synapse between neurons. The traditional picture of a synapse was that the axon terminal and the postsynaptic spine are separated by “extracellular space” filed with cytoplasm. The exosome was pictured as crossing this fluid cytoplasm. However, electron microscopy shows that such “space” is vanishingly thin. Instead, the “space” is mainly filled with astrocyte cuffs tightly packed around the central part of the synapse plus a network of nanotubes and fibers crossing the central part (32–35). This central part is specialized for the transmission of neurotransmitter molecules, and the outer ring for the transmission of exosomes (36). Astrocytes both receive (37) and bud off (38, 39) exosomes, so it is likely that exosomes cross the synapse via the astrocyte cuff and nanotubules. Much of the load carried by exosomes consists of epigenetic material (protein transcription factors, a wide variety of RNAs, and lengths of DNA). Epigenetic material consists of four main categories: (a) molecules that act directly on DNA by promoting co-valent binding (e.g., DNA methylases and demethylases) or non-co-valent binding (e.g., protein transcription factors); (b) agents that module the accessibility of DNA by promoting co-valent binding to histones (e.g., histone methylases and acetylases); (c) mRNAs that induce de novo protein synthesis in the target cell; and (d) micro RNAs that bind to mRNAs and modulate their activity (28). Exosomes from different types of cell carry different patterns of these transcription factors in their loads. In many cells, such as neurons, exosome formation is closely modulated by the degree of activity of that cell. For example, activation of glutamate receptors leads to a marked increase in exosome production mediated by calcium inflow. The exact composition of exosome loads is also exquisitely sensitive to the functional condition of the donor cell. For example, when a normal cell becomes cancerous, the ingredients of the load that its exosomes carry changes dramatically (28). Furthermore, the surfaces of different types of exosomes carry different patterns of glycosylation that can act as identifying signals, so that the exosome will bind to complementary patterns of glycosylation on the correct target cell (40). Other possible identification molecules that would allow an exosome to bind to its proper target are the heparin sulfate proteoglycans (HSPGs). Exosomes have been shown to enter cells via HSPG-mediated endocytosis. Heparanse enzyme activity is required for robust enhancement of exosome secretion (41–44). Exosomes from cancer cells depend on cell-surface HSPGs for their internalization and functional activity (30). This scenario offers an exciting new paradigm. Firstly, exosomes released from the apical or basolateral surface of gastrointestinal epithelium may contribute to antimicrobial defenses in the gut lumen. Secondly, and more interestingly, exosomes may be transported to the MLN where they modulate, by the epigenetic mechanisms listed above, host adaptive responses to luminal antigens. We are thus suggesting that there are two channels of communication between intestinal epithelial cells and target T cells in lymph nodes. The first transmits information (“software”) reflecting the contents of the gut, obtained and transmitted by DCs in the manner described earlier. The second channel transmits epigenetic instructions, in particular specific miRNAs, via exosomes to the T cell, so that it can develop the optimum molecular mechanisms or reactions (“hardware”) to process the incoming “software.” A similar system is found in the nervous system (28): information about the environment is transmitted by spike codes in axons (“software”) and instructions on how to best process this software is transmitted by epigenetic molecules via contained within exosomes. Together this results in changes in the basic functions of the receiving neurons by altering the synthesis of key proteins that play an essential role in these processes. Funding support is provided by National Institutes of Health grant AI-83539, The Broad Medical Research Program of The Broad Foundation, and The Crohn’s and Colitis Foundation of America. We are grateful to Sasha Vlassov for the benefit of helpful information. 1. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 124:837–48. doi: 10.1016/j.cell.2006.02.017 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 2. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature (2012) 489:231. doi:10.1038/nature11551 CrossRef Full Text 3. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev (1998) 62:1157. Pubmed Abstract | Pubmed Full Text 4. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol (2004) 4:478. doi:10.1038/nri1373 CrossRef Full Text 5. Duan J, Chung H, Troy E, Kasper DL. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe (2010) 7:140. doi:10.1016/j.chom.2010.01.005 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 6. Niess JH, Leithäuser F, Adler G, Reimann J. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol (2008) 180:559. Pubmed Abstract | Pubmed Full Text 7. Lundin A, Bok CM, Aronsson L, Björkholm B, Gustafsson JA, Pott S, et al. Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication that tunes innate immunity in large intestine. Cell Microbiol (2008) 10:1093. doi:10.1111/j.1462-5822.2007.01108.x Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 8. Smythies LE, Shen R, Bimczok D, Novak L, Clements RH, Eckhoff DE, et al. Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation. J Biol Chem (2010) 285:19593–604. doi:10.1074/jbc.M109.069955 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 9. Smith PD, Smythies LE, Shen R, Greenwell-Wild T, Gliozzi M, Wahl SM. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2011) 1:31–42. doi:10.1038/mi.2010.66 CrossRef Full Text 10. Farache J, Koren I, Milo I, Gurevich I, Kim K-W, Zigmond E, et al. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity (2013) 38:581–95. doi:10.1016/j.immuni.2013.01.009 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 11. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest (2005) 115:66–75. doi:10.1172/JCI200519229 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 12. McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, Knoop KA, et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature (2012) 483:345–9. doi:10.1038/nature10863 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 13. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (2005) 307:254–8. Pubmed Abstract | Pubmed Full Text 14. Chieppa M, Rescigno M, Huang AY, Germain RN. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp Med (2006) 203:2841–52. doi:10.1084/jem.20061884 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 15. Farache J, Zigmond E, Shakhar G, Jung S. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense. Immunol Cell Biol (2013) 91:232–9. doi:10.1038/icb.2012.79 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 16. Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, et al. Origin of the lamina propria dendritic cell network. Immunity (2009) 31:513–25. doi:10.1016/j.immuni.2009.08.010 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 17. Schulz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW, et al. Intestinal CD103þ, but not CX3CR1þ, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med (2009) 206:3101–14. doi:10.1084/jem.20091925 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 18. Johansson-Lindbom B, Svensson M, Pabst O, Palmqvist C, Marquez G, Förster R, et al. Functional specialization of gut CD103 dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med (2005) 202:1063–73. doi:10.1084/jem.20051100 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 19. Jaensson E, Uronen-Hansson H, Pabst O, Eksteen B, Tian J, Coombes JL, et al. Small intestinal CD103þ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med (2008) 205:2139–49. doi:10.1084/jem.20080414 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 20. Mallegol J, Van Niel G, Lebreton C, Lepelletier Y, Candalh C, Dugave C, et al. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells. J Gastro. (2007) 132:1866. doi:10.1053/j.gastro.2007.02.043 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 21. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology (2001) 121:337–49. 22. Hu G, Gong AY, Roth AL, Huang BQ, Ward HD, Zhu G, et al. Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. Plos Pathog (2013) 9. doi:10.1371/journal.ppat.1003261 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 23. Chen X, Song CH, Feng BS, Li TL, Li P, Zheng PY, et al. Intestinal epithelial cell-derived integrin αβ6 plays an important role in the induction of regulatory T cells and inhibits an antigen-specific Th2 response. J Leuko Biol (2006) 90:751–9. doi:10.1189/jlb.1210696 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 24. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol (2002) 2:569–79. 25. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet (2002) 360:295–305. doi:10.1016/S0140-6736(02)09552-1 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 26. Smalheiser NR. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct (2007) 2:35. doi:10.1186/1745-6150-2-35 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 27. Hendrix A, Westbroek W, Bracke M, Wever OD. An ex(o)citing machinery for invasive tumor growth. Cancer Res (2010) 70:9533–7. doi:10.1158/0008-5472.CAN-10-3248 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 28. Smythies J, Edelstein L. Transsynaptic modality codes in the brain: possible involvement of synchronized spike timing, microRNAs, exosomes and epigenetic processes. Front Intregr Neurosci (2013) 2012(6):126. doi:10.3389/fnint.2012.00126 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 29. Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med (2011) 9:86. doi:10.1186/1479-5876-9-86 Pubmed Abstract | Pubmed Full Text | CrossRef Full Text 30. Nanbo A, Kawanishi E, Yoshida R, Yoshiyama H. Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote...
- 1 September 2011
- Published by Elsevier in Gastroenterology
- Vol. 141 (3) , 929-938
Stromal Regulation of Human Gastric Dendritic Cells Restricts the Th1 Response to Helicobacter pylori
- 1 September 2011
- Published by Elsevier in Gastroenterology
- Vol. 141 (3) , 929-938
Stromal Regulation of Human Gastric Dendritic Cells Restricts the Th1 Response to Helicobacter pylori
- 1 July 2011
- Published by Elsevier in Mucosal Immunology
- Vol. 4 (4) , 420-427
Extracellular matrix-associated cytokines regulate CD4+ effector T-cell responses in the human intestinal mucosa
- 1 July 2011
- Published by Elsevier in Mucosal Immunology
- Vol. 4 (4) , 420-427
Extracellular matrix-associated cytokines regulate CD4+ effector T-cell responses in the human intestinal mucosa
- Open Access
- 1 June 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (25) , 19593-19604
Inflammation Anergy in Human Intestinal Macrophages Is Due to Smad-induced IκBα Expression and NF-κB Inactivation
- 1 June 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (25) , 19593-19604
Open AccessInflammation Anergy in Human Intestinal Macrophages Is Due to Smad-induced IκBα Expression and NF-κB Inactivation
- Open Access
- 17 March 2010
- Published by Elsevier in Mucosal Immunology
- Vol. 3 (3) , 260-269
Human primary gastric dendritic cells induce a Th1 response to H. pylori
- 17 March 2010
- Published by Elsevier in Mucosal Immunology
- Vol. 3 (3) , 260-269
Open AccessHuman primary gastric dendritic cells induce a Th1 response to H. pylori
- 27 January 2007
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 27 (2) , 201-209
Gliadin Peptides Activate Blood Monocytes from Patients with Celiac Disease
To elucidate the role of innate immune responses in celiac disease, we investigated the effect of gliadin on blood monocytes from patients with celiac disease. Gliadin induced substantial TNF-α and IL-8 production by monocytes from patients with active celiac disease, lower levels by monocytes from patients with inactive celiac disease, and even lower levels by monocytes from healthy donors. In healthy donor monocytes gliadin induced IL-8 from monocytes expressing HLA-DQ2 and increased monocyte expression of the costimulatory molecules CD80 and CD86, the dendritic cell marker CD83, and the activation marker CD40. Gliadin also increased DNA binding activity of NF-κB p50 and p65 subunits in monocytes from celiac patients, and NF-κB inhibitors reduced both DNA binding activity and cytokine production. Thus, gliadin activation of HLA-DQ2+ monocytes leading to chemokine and proinflammatory cytokine production may contribute to the host innate immune response in celiac disease.
- 27 January 2007
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 27 (2) , 201-209
Gliadin Peptides Activate Blood Monocytes from Patients with Celiac Disease
To elucidate the role of innate immune responses in celiac disease, we investigated the effect of gliadin on blood monocytes from patients with celiac disease. Gliadin induced substantial TNF-α and IL-8 production by monocytes from patients with active celiac disease, lower levels by monocytes from patients with inactive celiac disease, and even lower levels by monocytes from healthy donors. In healthy donor monocytes gliadin induced IL-8 from monocytes expressing HLA-DQ2 and increased monocyte expression of the costimulatory molecules CD80 and CD86, the dendritic cell marker CD83, and the activation marker CD40. Gliadin also increased DNA binding activity of NF-κB p50 and p65 subunits in monocytes from celiac patients, and NF-κB inhibitors reduced both DNA binding activity and cytokine production. Thus, gliadin activation of HLA-DQ2+ monocytes leading to chemokine and proinflammatory cytokine production may contribute to the host innate immune response in celiac disease.